Holen Sie sich die Stockscreener-App
1.69
1.81%
0.03
Vorhandelsmarkt:
1.66
-0.03
-1.78%
Schlusskurs vom Vortag:
$1.66
Offen:
$1.665
24-Stunden-Volumen:
44,767
Relative Volume:
0.02
Marktkapitalisierung:
$7.60M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-2.0864
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+7.64%
1M Leistung:
-19.14%
6M Leistung:
-81.08%
1J Leistung:
-94.19%
1-Tages-Spanne:
$1.64
$1.74
1-Wochen-Bereich:
$1.55
$1.7899
52-Wochen-Spanne:
$1.25
$46.53
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
1.69 | 7.47M | 9.37M | -8.45M | -7.27M | -0.81 |
|
TMO
Thermo Fisher Scientific Inc
|
573.81 | 211.55B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.42 | 157.68B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.83 | 55.82B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
143.47 | 39.81B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.92 | 37.14B | 15.90B | 1.28B | 2.21B | 7.2842 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
Reviewing bioAffinity Technologies (NASDAQ:BIAF) and Briacell Therap (NASDAQ:BCTX) - Defense World
bioAffinity Technologies Inc. (BIAF) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why bioAffinity Technologies Inc. stock could outperform in 2025Trade Risk Assessment & Growth Oriented Trading Recommendations - Newser
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society - PharmiWeb.com
bioAffinity Technologies’ Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable - BioSpace
bioAffinity Technologies to Present at Cancer Roundtable - TipRanks
bioAffinity Technologies, Inc. to Present CyPath® Lung Test at ACS Roundtable - TradingView
Certain Warrants of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
Certain Convertible Preferred Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
1,375,102 Common Stock of bioAffinity Technologies, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com
bioAffinity Technologies Inc trading halted, volatility trading pause - MSN
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules (PR Newswire) - Aktiellt
Aug Action: Why bioAffinity Technologies Inc. stock could be next big winner - BỘ NỘI VỤ
bioAffinity Technologies Reports Strong Growth in Lung Test Revenue - MSN
How bioAffinity Technologies Inc. stock benefits from global expansionGDP Growth & Fast Exit Strategy with Risk Control - moha.gov.vn
Investment Review: Why retail investors pile into bioAffinity Technologies Inc. stockJuly 2025 Analyst Calls & Risk Controlled Daily Trade Plans - moha.gov.vn
Earnings roundup: Q3 rocky for bioAffinity and Spurs concessionaire - San Antonio Express-News
Is bioAffinity Technologies Inc Equity Warrant a good long term investmentMean Reversion Trades & Rapid Portfolio Gain - earlytimes.in
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss - MSN
bioAffinity Technologies Reports Surge in CyPath® Lung Tests - MSN
How bioAffinity Technologies Inc. stock benefits from tech adoptionJuly 2025 Momentum & Weekly Breakout Stock Alerts - newser.com
Is bioAffinity Technologies Inc. stock cheap compared to fundamentalsTrade Volume Summary & Weekly Stock Breakout Alerts - newser.com
Will bioAffinity Technologies Inc. stock deliver strong dividend growthWeekly Volume Report & Real-Time Market Sentiment Reports - newser.com
Will bioAffinity Technologies Inc. stock recover faster than marketJuly 2025 Update & AI Optimized Trading Strategy Guides - newser.com
Is bioAffinity Technologies Inc. stock a buy for dividend growth2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Volume spikes in bioAffinity Technologies Inc. Equity Warrant stock – what they mean2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is bioAffinity Technologies Inc. meeting your algorithmic filter criteriaProduct Launch & Fast Exit and Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock oversold or undervaluedTrade Exit Summary & AI Based Buy and Sell Signals - newser.com
Maxim Group Sticks to Its Buy Rating for bioAffinity Technologies, Inc. (BIAF) - The Globe and Mail
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trendsPortfolio Return Report & AI Enhanced Execution Alerts - newser.com
Why bioAffinity Technologies Inc. stock is seen as undervalued2025 Institutional Moves & Verified Swing Trading Watchlists - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
What recovery options are there for bioAffinity Technologies Inc.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Is bioAffinity Technologies Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Reliable Intraday Trade Alerts - newser.com
MSN Money - MSN
Is bioAffinity Technologies Inc. stock attractive for growth ETFs2025 Historical Comparison & Free Growth Oriented Trading Recommendations - newser.com
Can momentum traders help lift bioAffinity Technologies Inc. Equity WarrantMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock outperform Dow Jones indexMarket Activity Report & High Accuracy Investment Signals - newser.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.10%
1.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):